Partnering with Management

Our proprietary deal flow has favorably positioned our team to make strategic investments in unique opportunities including funds and companies around the world. Our advisory group routinely reviews opportunities into which we can invest or co-invest. Our firm brings a unique financial and operating due diligence perspective to these opportunities. The following is a list of our key parameters:

Parameters

• Primary interest in the healthcare sector
• Select buyout, distressed and mezzanine funds that align with our strategic initiatives
• Investment size typically $500,000 – $5,000,000 of convertible preferred or junior debt investments

Select Investments

• King Pharmaceuticals (NYSE:KG)
• Theramed Corporation
• BurnsAdler Pharmaceuticals
• CommScope, Inc.
   

Select Fund Investments

• Irving Place Capital (IPC), Fund II - 2000
• Irving Place Capital (IPC), Fund III - 2006
• Carlyle Partners IV - 2005
• Carlyle Partners V - 2007
• Carlyle Europe Partners III - 2007 
• Carlyle Strategic Partners II - 2007
• Carlyle Global Financial Services Partners - 2010
• Carlyle South America Buyout Fund - 2010
• Carlyle Realty Partners VI - 2011

Contact Banks Bourne for more information on principal investing at bbourne@bourne-partners.com 704-714-8350.